Hypertension Research最新文献

筛选
英文 中文
Preface-risk of hypertension to cardiovascular disease and beneficial effects of drugs 前言--高血压对心血管疾病的风险和药物的益处。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-16 DOI: 10.1038/s41440-024-01794-5
Masaki Mogi, Satoshi Hoshide, Kazuomi Kario
{"title":"Preface-risk of hypertension to cardiovascular disease and beneficial effects of drugs","authors":"Masaki Mogi, Satoshi Hoshide, Kazuomi Kario","doi":"10.1038/s41440-024-01794-5","DOIUrl":"10.1038/s41440-024-01794-5","url":null,"abstract":"","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01794-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood pressure time at target and its prognostic value for cardiovascular outcomes: a scoping review 血压达标时间及其对心血管后果的预后价值:范围综述。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-16 DOI: 10.1038/s41440-024-01798-1
Wansha Li, Sonali R. Gnanenthiran, Aletta E. Schutte, Isabella Tan
{"title":"Blood pressure time at target and its prognostic value for cardiovascular outcomes: a scoping review","authors":"Wansha Li, Sonali R. Gnanenthiran, Aletta E. Schutte, Isabella Tan","doi":"10.1038/s41440-024-01798-1","DOIUrl":"10.1038/s41440-024-01798-1","url":null,"abstract":"The proportion of time that blood pressure (BP) readings are at treatment target levels, commonly referred to as time at target or time in therapeutic range (BP-TTR), is emerging as a useful measure for evaluating hypertension management effectiveness and assessing longitudinal BP control. However, method of determination for BP-TTR differs across studies. This review identifies variations in BP-TTR determination methodologies and its potential prognostic value for cardiovascular outcomes. Following PRISMA extension for scoping reviews guidelines, literature was systematically searched in Embase, PubMed, Scopus, Web of Science, and CINAHL. Relevant clinical trials, observational studies, cohort studies, cross-sectional studies, and systematic reviews published in English were screened. Of 369 articles identified, 17 articles were included. Studies differed in the BP targets used (e.g., BP < 140/90 mmHg or 130/80 mmHg; systolic BP within 110–130 mmHg or 120–140 mmHg), BP-TTR measurement duration (range 24 h to 15 years), and calculation method (linear interpolation method, n = 12 [71%]; proportion of BP readings at target, n = 5 [29%]). Regardless of method, studies consistently demonstrated that higher BP-TTR was associated with reduced risk of cardiovascular outcomes. Six of eight studies found the association was independent of mean achieved BP or last measured BP. Despite variation in methods of BP-TTR determination, these studies demonstrated the potential prognostic value of BP-TTR for cardiovascular outcomes beyond current BP control measures. We recommend standardization of BP-TTR methodology, with preference for linear interpolation method when BP measurements are few or less frequent, and proportion of BP readings method when large number of BP readings are available.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01798-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long term worsening of arterial stiffness from monitoring of QKD interval predicts the occurrence of cardiovascular events 通过监测 QKD 间期,动脉僵化的长期恶化可预测心血管事件的发生。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-16 DOI: 10.1038/s41440-024-01799-0
Philippe Gosse, Julien Doublet, Julie Gaudissard, Lauryne Debois, Antoine Cremer
{"title":"Long term worsening of arterial stiffness from monitoring of QKD interval predicts the occurrence of cardiovascular events","authors":"Philippe Gosse, Julien Doublet, Julie Gaudissard, Lauryne Debois, Antoine Cremer","doi":"10.1038/s41440-024-01799-0","DOIUrl":"10.1038/s41440-024-01799-0","url":null,"abstract":"Arterial stiffness is an independent predictor of cardiovascular events in different populations. Destiffening appears to be possible through the control of the main cardiovascular risk factors, with however important individual variations. There are so far too few data available on the prognostic importance of changes in arterial stiffness. We tested the consequences of changes in arterial stiffness assessed with the QKD method on the incidence of cardiovascular events in a cohort of hypertensive patients. The change of QKD100-60 was calculated as the difference between baseline and last follow-up value. Patients were classified as group 0 with stable or increased QKD100-60 and group 1 with decreased QKD100-60 (increased arterial stiffness). The prognostic of these two groups was analysed with a Cox model including age, baseline QKD100-60, 24 h SBP (baseline and change), delay between first and last recording, sex, diabetes, smoking, and hypercholesterolemia. We included 555 essential hypertensive patients with 24 h ambulatory measurement of BP and QKD at baseline and follow-up. The follow-up period was 12.28 ± 7.38 years with an average time between baseline and last recording of 8.86 ± 6.48 years. 94 cardiovascular events occurred. The group with increased arterial stiffness shows the double risk of occurrence of cardiovascular event than the group with stable or reduced arterial stiffness independently of other factors including changes in 24 h SBP.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141626559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Atrial fibrillation, hypertension, and the cerebral vasodilatory reserve 更正:心房颤动、高血压和脑血管舒张储备。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-16 DOI: 10.1038/s41440-024-01806-4
Takayuki Katayama, Kae Takahashi, Osamu Yahara
{"title":"Correction: Atrial fibrillation, hypertension, and the cerebral vasodilatory reserve","authors":"Takayuki Katayama, Kae Takahashi, Osamu Yahara","doi":"10.1038/s41440-024-01806-4","DOIUrl":"10.1038/s41440-024-01806-4","url":null,"abstract":"","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01806-4.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Will esaxerenone be added to the antihypertensive treatment strategy of practicing physicians as a second-line antihypertensive drug? 埃沙塞酮是否会作为二线降压药物被纳入执业医生的降压治疗策略?
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-11 DOI: 10.1038/s41440-024-01802-8
Tetsuro Yoshida
{"title":"Will esaxerenone be added to the antihypertensive treatment strategy of practicing physicians as a second-line antihypertensive drug?","authors":"Tetsuro Yoshida","doi":"10.1038/s41440-024-01802-8","DOIUrl":"10.1038/s41440-024-01802-8","url":null,"abstract":"","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01802-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141585928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Depressive symptoms as risk factors for the onset of home hypertension: a prospective cohort study. 作为家庭高血压发病风险因素的抑郁症状:一项前瞻性队列研究。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-10 DOI: 10.1038/s41440-024-01790-9
Sayuri Tokioka, Naoki Nakaya, Rieko Hatanaka, Kumi Nakaya, Mana Kogure, Ippei Chiba, Kotaro Nochioka, Hirohito Metoki, Takahisa Murakami, Michihiro Satoh, Tomohiro Nakamura, Mami Ishikuro, Taku Obara, Yohei Hamanaka, Masatsugu Orui, Tomoko Kobayashi, Akira Uruno, Eiichi N Kodama, Satoshi Nagaie, Soichi Ogishima, Yoko Izumi, Nobuo Fuse, Shinichi Kuriyama, Atsushi Hozawa
{"title":"Depressive symptoms as risk factors for the onset of home hypertension: a prospective cohort study.","authors":"Sayuri Tokioka, Naoki Nakaya, Rieko Hatanaka, Kumi Nakaya, Mana Kogure, Ippei Chiba, Kotaro Nochioka, Hirohito Metoki, Takahisa Murakami, Michihiro Satoh, Tomohiro Nakamura, Mami Ishikuro, Taku Obara, Yohei Hamanaka, Masatsugu Orui, Tomoko Kobayashi, Akira Uruno, Eiichi N Kodama, Satoshi Nagaie, Soichi Ogishima, Yoko Izumi, Nobuo Fuse, Shinichi Kuriyama, Atsushi Hozawa","doi":"10.1038/s41440-024-01790-9","DOIUrl":"10.1038/s41440-024-01790-9","url":null,"abstract":"<p><p>Depression is comorbid with somatic diseases; however, the relationship between depressive symptoms and hypertension (HT), a risk factor for cardiovascular events, remains unclear. Home blood pressure (BP) is more reproducible and accurately predictive of cardiovascular diseases than office BP. Therefore, we focused on home BP and investigated whether depressive symptoms contributed to the future onset of home HT. This prospective cohort study used data from the Tohoku Medical Megabank Community-Cohort Study (conducted in the Miyagi Prefecture, Japan) and included participants with home normotension (systolic blood pressure (SBP) < 135 mmHg and diastolic blood pressure (DBP) < 85 mmHg). Depressive symptoms were evaluated using the Center for Epidemiologic Studies Depression Scale-Japanese version at the baseline survey. In the secondary survey, approximately 4 years later, the onset of home HT was evaluated (SBP ≥ 135 mmHg or DBP ≥ 85 mmHg) and was compared in participants with and without depressive symptoms. Of the 3 082 (mean age: 54.2 years; females: 80.9%) participants, 729 (23.7%) had depressive symptoms at the baseline survey. During the 3.5-year follow-up, 124 (17.0%) and 388 (16.5%) participants with and without depressive symptoms, respectively, developed home HT. Multivariable adjusted odds ratios were 1.37 (95% confidence interval (CI): 1.02-1.84), 1.18 (95% CI: 0.86-1.61), and 1.66 (95% CI: 1.17-2.36) for home, morning, and evening HT, respectively. This relationship was consistent in the subgroup analyses according to age, sex, BP pattern, and drinking habit. Depressive symptoms increased the risk of new-onset home HT, particularly evening HT, among individuals with home normotension. This prospective cohort study revealed that depressive symptoms are risk factors for new-onset home hypertension, particularly evening hypertension among individuals with home normotension. Assessing home blood pressure in individuals with depressive symptoms is important for the prevention of hypertension and concomitant cardiovascular diseases.</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of polygenic risk score and sodium and potassium intake on hypertension in Asians: A nationwide prospective cohort study. 多基因风险评分和钠钾摄入量对亚洲人高血压的影响:一项全国范围的前瞻性队列研究。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-10 DOI: 10.1038/s41440-024-01784-7
Bae Eunjin, Yunmi Ji, Jinyeon Jo, Yaerim Kim, Jung Pyo Lee, Sungho Won, Jeonghwan Lee
{"title":"Effects of polygenic risk score and sodium and potassium intake on hypertension in Asians: A nationwide prospective cohort study.","authors":"Bae Eunjin, Yunmi Ji, Jinyeon Jo, Yaerim Kim, Jung Pyo Lee, Sungho Won, Jeonghwan Lee","doi":"10.1038/s41440-024-01784-7","DOIUrl":"10.1038/s41440-024-01784-7","url":null,"abstract":"<p><p>Genetic factors, lifestyle, and diet have been shown to play important roles in the development of hypertension. Increased salt intake is an important risk factor for hypertension. However, research on the involvement of genetic factors in the relationship between salt intake and hypertension in Asians is lacking. We aimed to investigate the risk of hypertension in relation to sodium and potassium intake and the effects of genetic factors on their interactions. We used Korean Genome and Epidemiology Study data and calculated the polygenic risk score (PRS) for the effect of systolic and diastolic blood pressure (SBP and DBP). We also conducted multivariable logistic modeling to evaluate associations among incident hypertension, PRS<sub>SBP</sub>, PRS<sub>DBP</sub>, and sodium and potassium intake. In total, 41,351 subjects were included in the test set. The top 10% PRS<sub>SBP</sub> group was the youngest of the three groups (bottom 10%, middle, top 10%), had the highest proportion of women, and had the highest body mass index, baseline BP, red meat intake, and alcohol consumption. The multivariable logistic regression model revealed the risk of hypertension was significantly associated with higher PRS<sub>SBP</sub>, higher sodium intake, and lower potassium intake. There was significant interaction between sodium intake and PRS<sub>SBP</sub> for incident hypertension especially in sodium intake ≥2.0 g/day and PRS<sub>SBP</sub> top 10% group (OR 1.27 (1.07-1.51), P = 0.007). Among patients at a high risk of incident hypertension due to sodium intake, lifestyle modifications and sodium restriction were especially important to prevent hypertension.</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and meta-analysis. 远程医疗/远程保健的数字健康干预措施对成人血压管理的有效性:系统综述和荟萃分析。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-09 DOI: 10.1038/s41440-024-01792-7
Atsushi Sakima, Yuya Akagi, Yuichi Akasaki, Takako Fujii, Tatsuya Haze, Fumiko Kawakami-Mori, Ken Kitajima, Yusuke Kobayashi, Tetsutaro Matayoshi, Takashi Sakaguchi, Masanobu Yamazato, Makiko Abe, Yusuke Ohya, Hisatomi Arima
{"title":"Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and meta-analysis.","authors":"Atsushi Sakima, Yuya Akagi, Yuichi Akasaki, Takako Fujii, Tatsuya Haze, Fumiko Kawakami-Mori, Ken Kitajima, Yusuke Kobayashi, Tetsutaro Matayoshi, Takashi Sakaguchi, Masanobu Yamazato, Makiko Abe, Yusuke Ohya, Hisatomi Arima","doi":"10.1038/s41440-024-01792-7","DOIUrl":"10.1038/s41440-024-01792-7","url":null,"abstract":"<p><p>This systematic review and meta-analysis included randomized controlled trials or observational studies that compare digital health interventions (DHIs) for telemedicine/telehealth versus usual care for managing blood pressure (BP) in adults. We searched PubMed, Cochrane CENTRAL, and IchuShi-Web, and used a random-effects meta-analysis of the weighted mean difference (MD) between the comparison groups to pool data from the included studies. The outcome included the pooled MD of office BP from baseline to each follow-up period. This meta-analysis considered 117 studies with 68677 participants as eligible. The 3-month intervention period reduced office systolic BP (SBP) compared with usual care in 38 studies (MD: -3.21 mmHg [95% confidence interval: -4.51 to -1.90]), with evidence of heterogeneity. Office SBP across intervention periods demonstrated comparable effects (3-, 6- [54 studies], 12- [43 studies], and >12-month periods [9 studies]). The benefits for office diastolic BP were similar to those for office SBP. Additionally, the interventions significantly reduced the office SBP compared with the control, regardless of the mode of intervention delivery (smartphone apps [38 studies], text messages [35 studies], and websites [34 studies]) or type of facility (medical [74 studies] vs. non-medical [33 studies]). The interventions were more effective in 41 hypertension cohorts compared with 66 non-hypertension cohorts (-4.81 mmHg [-6.33, -3.29] vs. -2.17 mmHg [-3.15, -1.19], P = 0.006 for heterogeneity). In conclusion, DHIs for telemedicine/telehealth improved BP management compared with usual care. The effectiveness with heterogeneity should be considered, as prudent for implementing evidence-based medicine. This meta-analysis considered 117 studies with 68677 participants eligible. The DHIs for telemedicine/telehealth reduced office BP compared with usual care, regardless of intervention duration, intervention delivery mode, facility type, and cohort type. Additionally, the DHIs reduced the risk of uncontrolled BP compared with usual care, regardless of intervention duration, intervention delivery mode, and facility type. BP blood pressure, DHI digital health intervention, MD mean difference, RR risk ratio, SBP systolic blood pressure.</p>","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial 中风后基于西洛他唑的长期双联抗血小板疗法期间的血压:CSPS.com 试验的事后分析。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-09 DOI: 10.1038/s41440-024-01742-3
Kazunori Toyoda, Masatoshi Koga, Kenta Tanaka, Shinichiro Uchiyama, Hisato Sunami, Katsuhiro Omae, Kazumi Kimura, Haruhiko Hoshino, Mayumi Fukuda-Doi, Kaori Miwa, Junpei Koge, Yasushi Okada, Nobuyuki Sakai, Kazuo Minematsu, Takenori Yamaguchi, for the CSPS.com Trial Investigators
{"title":"Blood pressure during long-term cilostazol-based dual antiplatelet therapy after stroke: a post hoc analysis of the CSPS.com trial","authors":"Kazunori Toyoda,&nbsp;Masatoshi Koga,&nbsp;Kenta Tanaka,&nbsp;Shinichiro Uchiyama,&nbsp;Hisato Sunami,&nbsp;Katsuhiro Omae,&nbsp;Kazumi Kimura,&nbsp;Haruhiko Hoshino,&nbsp;Mayumi Fukuda-Doi,&nbsp;Kaori Miwa,&nbsp;Junpei Koge,&nbsp;Yasushi Okada,&nbsp;Nobuyuki Sakai,&nbsp;Kazuo Minematsu,&nbsp;Takenori Yamaguchi,&nbsp;for the CSPS.com Trial Investigators","doi":"10.1038/s41440-024-01742-3","DOIUrl":"10.1038/s41440-024-01742-3","url":null,"abstract":"We determined the associations of follow-up blood pressure (BP) after stroke as a time-dependent covariate with the risk of subsequent ischemic stroke, as well as those of BP levels with the difference in the impact of long-term clopidogrel or aspirin monotherapy versus additional cilostazol medication on secondary stroke prevention. In a sub-analysis of a randomized controlled trial (CSPS.com), patients between 8 and 180 days after stroke onset were randomly assigned to receive aspirin or clopidogrel alone, or a combination of cilostazol with aspirin or clopidogrel. The percent changes, differences, and raw values of follow-up BP were examined. The primary efficacy outcome was the first recurrence of ischemic stroke. In a total of 1657 patients (69.5 ± 9.3 years, female 29.1%) with median 1.5-year follow-up, ischemic stroke recurred in 74 patients. The adjusted hazard ratio for ischemic stroke of a 10% systolic BP (SBP) increase from baseline was 1.19 (95% CI 1.03–1.36), that of a 10 mmHg SBP increase was 1.14 (1.03–1.28), and that of SBP as the raw value with the baseline SBP as a fixed (time-independent) covariate was 1.14 (1.00–1.31). Such significant associations were not observed in diastolic BP-derived variables. The estimated adjusted hazard ratio curves for the outcome showed the benefit of dual therapy over a wide SBP range between ≈120 and ≈165 mmHg uniformly. Lower long-term SBP levels after ischemic stroke were associated with a lower risk of subsequent ischemic events. The efficacy of dual antiplatelet therapy including cilostazol for secondary stroke prevention was evident over a wide SBP range.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01742-3.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141558591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dissecting the vascular-cognitive nexus: energetic vs. conventional hemodynamic parameters 剖析血管与认知之间的联系:能量与传统血液动力学参数。
IF 4.3 2区 医学
Hypertension Research Pub Date : 2024-07-09 DOI: 10.1038/s41440-024-01735-2
Hao-Min Cheng, Jiun-Jr Wang, Shao-Yuan Chuang, Chen-Hua Lin, Gary F. Mitchell, Chi-Jung Huang, Pei-Ning Wang, Chih-Ping Chung, Liang-Kung Chen, Wen-Harn Pan, Li-Ning Peng, Chen-Huan Chen
{"title":"Dissecting the vascular-cognitive nexus: energetic vs. conventional hemodynamic parameters","authors":"Hao-Min Cheng,&nbsp;Jiun-Jr Wang,&nbsp;Shao-Yuan Chuang,&nbsp;Chen-Hua Lin,&nbsp;Gary F. Mitchell,&nbsp;Chi-Jung Huang,&nbsp;Pei-Ning Wang,&nbsp;Chih-Ping Chung,&nbsp;Liang-Kung Chen,&nbsp;Wen-Harn Pan,&nbsp;Li-Ning Peng,&nbsp;Chen-Huan Chen","doi":"10.1038/s41440-024-01735-2","DOIUrl":"10.1038/s41440-024-01735-2","url":null,"abstract":"Blood pressure or flow measurements have been associated with&nbsp;vascular health and cognitive function. We proposed that energetic hemodynamic parameters may provide a more nuanced understanding and stronger correlation with cognitive function, in comparisons with conventional aortic and carotid pressure and flow parameters. The study comprised 1858 participants, in whom we assessed cognitive function via MoCA method, and measured central aortic and carotid pressure and flow waveforms. In addition to various pressure and flow parameters, we calculated energetic hemodynamic parameters through integration of pressure multiplying flow with respect to time. Energetic hemodynamic parameters, particularly aortic and carotid mean and pulsatile energy and pulsatility index (PI), were significantly associated with MoCA score more than any aortic and carotid pressure and flow parameters, after adjusting for age, sex, education, depression score, heart rate, BMI, HDL-cholesterol, and glucose levels. MoCA exhibited a strong positive relationship with carotid mean energy (standardized beta = 0.053, P = 0.0253) and a negative relationship with carotid energy PI (standardized beta = −0.093, P = 0.0002), exceeding the association with all traditional pressure- or flow-based parameters. Aortic pressure reflection coefficient at the aorto-carotid junction was positively correlated with mean carotid energy and negatively correlated with PI. Aortic characteristic impedance positively correlated with carotid energy PI but not mean energy. Our research indicates that energetic hemodynamic parameters, particularly carotid mean energy and carotid energy PI, have a stronger association with MoCA scores than traditional pressure- or flow-based metrics. This correlation with cognitive function is notably influenced by the properties of the aorto-carotid interface.","PeriodicalId":13029,"journal":{"name":"Hypertension Research","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41440-024-01735-2.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信